<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>The Harvard Law School Forum on Corporate Governance</title>
	<atom:link href="https://corpgov.law.harvard.edu/2022/01/30/theranos-the-limits-of-the-fake-it-till-you-make-it-strategy/feed/" rel="self" type="application/rss+xml" />
	<link>https://corpgov.law.harvard.edu</link>
	<description>The leading online blog in the fields of corporate governance and financial regulation.</description>
	<lastBuildDate>Tue, 07 Apr 2026 11:32:15 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.5.8</generator>

<image>
	<url>https://corpgov.law.harvard.edu/wp-content/uploads/2024/02/cropped-photography-4-e1706898544564-1-32x32.png</url>
	<title>Theranos: The Limits of the “Fake It Till You Make It” Strategy &#8211; The Harvard Law School Forum on Corporate Governance</title>
	<link>https://corpgov.law.harvard.edu</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>Theranos: The Limits of the “Fake It Till You Make It” Strategy</title>
		<link>https://corpgov.law.harvard.edu/2022/01/30/theranos-the-limits-of-the-fake-it-till-you-make-it-strategy/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=theranos-the-limits-of-the-fake-it-till-you-make-it-strategy</link>
		<comments>https://corpgov.law.harvard.edu/2022/01/30/theranos-the-limits-of-the-fake-it-till-you-make-it-strategy/#comments</comments>
		<pubDate>Sun, 30 Jan 2022 15:25:55 +0000</pubDate>
<!-- 		<dc:creator><![CDATA[]]></dc:creator> -->
				<category><![CDATA[Accounting & Disclosure]]></category>
		<category><![CDATA[Practitioner Publications]]></category>
		<category><![CDATA[Securities Litigation & Enforcement]]></category>
		<category><![CDATA[Corporate fraud]]></category>
		<category><![CDATA[Due diligence]]></category>
		<category><![CDATA[Institutional Investors]]></category>
		<category><![CDATA[Misconduct]]></category>
		<category><![CDATA[Securities fraud]]></category>
		<category><![CDATA[Securities litigation]]></category>
		<category><![CDATA[Tech companies]]></category>
		<category><![CDATA[Theranos]]></category>

		<guid isPermaLink="false">https://corpgov.law.harvard.edu/?p=142841?d=20220130102555EST</guid>
		<description><![CDATA[In a case that tested the limits of the “fake it till you make it” approach to a startup business, on January 3, 2022, a jury in the U.S. District Court for the Northern District of California convicted Elizabeth Holmes, founder and former CEO of now-defunct Theranos Inc., on one count of conspiracy to commit wire fraud [&#8230;]]]></description>
				<content:encoded><![CDATA[<hgroup><em>Posted by Carrie H. Cohen, James M. Koukios, and Christine Y. Wong, Morrison & Foerster LLP, on Sunday, January 30, 2022 </em><div class='e_n' style='background:#F8F8F8;padding:10px;margin-top:5px;margin-bottom:10px;text-indent:2.5em;'><strong style='margin-left:-2.5em;'>Editor's Note: </strong> <p style="margin:0; display:inline;"><a href="https://www.mofo.com/people/carrie-cohen.html">Carrie H. Cohen</a>, <a href="https://www.mofo.com/people/james-koukios.html">James M. Koukios</a>, and <a href="https://www.mofo.com/people/christine-wong.html">Christine Y. Wong</a> are partners at Morrison &amp; Foerster LLP. This post is based on a Morrison &amp; Foerster memorandum by Ms. Cohen, Mr. Koukios, Ms. Wong, <a href="https://www.mofo.com/people/sophie-cash.html">Sophie H. Cash</a>, and Rachael Hanna.</p>
</div></hgroup><p>In a case that tested the limits of the “fake it till you make it” approach to a startup business, on January 3, 2022, a jury in the U.S. District Court for the Northern District of California <a href="https://www.wsj.com/livecoverage/elizabeth-holmes-trial-theranos?mod=hp_lead_pos1" target="_blank" rel="noopener">convicted</a> Elizabeth Holmes, founder and former CEO of now-defunct Theranos Inc., on one count of conspiracy to commit wire fraud and three counts of wire fraud against Theranos investors. Each count carries a maximum sentence of 20 years in prison. The jury failed to reach a verdict on three additional counts of wire fraud against Theranos investors and found Holmes not guilty on the multiple counts of conspiracy and wire fraud against Theranos patients.</p>
<p>The trial, which lasted for 14 weeks, called into question more than just Holmes’ questionable business practices and investment solicitation; it was arguably a referendum on “fake it till you make it” practices, such as intentionally overstating, and thereby misrepresenting, a fledgling company’s current capabilities, success, or profitability, while banking on the notion that its aspirations will eventually follow the desired trajectory and become a reality. The case also highlighted the importance of investors doing adequate due diligence.</p>
<p> <a href="https://corpgov.law.harvard.edu/2022/01/30/theranos-the-limits-of-the-fake-it-till-you-make-it-strategy/#more-142841" class="more-link"><span aria-label="Continue reading Theranos: The Limits of the “Fake It Till You Make It” Strategy">(more&hellip;)</span></a></p>
]]></content:encoded>
			<wfw:commentRss>https://corpgov.law.harvard.edu/2022/01/30/theranos-the-limits-of-the-fake-it-till-you-make-it-strategy/feed/</wfw:commentRss>
		<slash:comments>2</slash:comments>
		</item>
	</channel>
</rss>
